B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NSD2

MOLECULAR TARGET

nuclear receptor binding SET domain protein 2

NCBI Gene: 7468186 compounds

NSD2 (nuclear receptor binding SET domain protein 2) is targeted by 186 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NSD2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dasatinib2.087
2Axitinib1.956
3Azathioprine1.956
4Bortezomib1.956
5Crizotinib1.956
6Disulfiram1.956
7Ouabain1.956
8Methylene Blue1.795
9Maprotiline1.795
10Atorvastatin1.614
11ag4901.614
12alpelisib1.614
13Methotrexate1.614
14Calcitriol1.614
15Chlorhexidine1.614
16Clofarabine1.614
17Colchicine1.614
18cycloheximide1.614
19Decitabine1.614
20Deferasirox1.614
21deguelin [Supplementary Concept]1.614
22Digitoxin1.614
23Digoxin1.614
24Emetine1.614
25Ethidium1.614
26Gemcitabine1.614
27Leflunomide1.614
28Melphalan1.614
29monorden1.614
30Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of1.614
31Nocodazole Nocodazole is1.614
32pictilisib1.614
33Podophyllotoxin1.614
34Proscillaridin1.614
35Sorafenib1.614
36sp6001251.614
37Thapsigargin1.614
38torin 11.614
39trichostatic acid [Supplementary Concept] related to trichostatin1.614
40Trifluridine1.614
41Tripterygium1.614
42vinblastine sulfate1.614
43Vincristine1.614
44withaferin1.614
45Daunorubicin1.393
46Dexrazoxane1.393
47Ethinyl Estradiol1.393
48Lovastatin1.393
49Apigenin 5,7,4'-trihydroxy-flavone,1.102
50Berberine1.102

Showing top 50 of 186 compounds. Use the BiohacksAI search to explore all NSD2 modulators.

About NSD2 as a Drug Target

NSD2 (nuclear receptor binding SET domain protein 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 186 compounds with documented NSD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NSD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.